Platelet activating factor receptor antagonists improve the efficacy of experimental chemo- and radiotherapy. Clinics [Internet]. 2019 Feb. 18 [cited 2024 May 3];73(Suppl. 1):e792s. Available from: https://www.revistas.usp.br/clinics/article/view/154887